Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland

AIDS

Volumn 3, Issue 5, 1989, Pages 267-272

  Donoghoe, Martin C ^a   Stimson, Gerry V ^a   Dolan, Kate ^a   Alldritt, Lindsey ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

HIV risk behaviour; IVDU; Syringe exchange

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG ABUSE; EDUCATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SYRINGE; UNITED KINGDOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COMPARATIVE STUDY; ENGLAND; FEMALE; HUMAN; INTERVIEWS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; PUBLIC HEALTH ADMINISTRATION; RISK-TAKING; SCOTLAND; SEX BEHAVIOR; SEXUAL PARTNERS; SUBSTANCE-RELATED DISORDERS; SUPPORT, NON-U.S. GOV'T; SYRINGES;

EID: 0024336072     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brettle RP: Epidemic of AIDS related virus infection among intravenous drug abusers. (Letter) Br Med J 1986, 292:1671.
2. Brettle RP, Davidson J, Davidson SJ, et al.: HTLV-III antibodies in an Edinburgh clinic. (Letter). Lancet 1986, 1:1099.
3. Robertson JR, Bucknall ABV, Wiggins P: Regional variations in HIV antibody seropositivity In British intravenous drug users. Lancet 1986, 1:1435.
4. Robertson JR, Bucknall ABV, Welsby PD, et al.: Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br Med J 1986, 292:527.
5. Webb G, Wells B, Morgan JR, McManus TJ: Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med J 1986, 292:1202.
6. Mulleady G, Green J: Syringe sharing among London drug abusers. (Letter) Lancet 1985, 11:1425.
7. Sheehan M, Oppenheimer E, Taylor C: Who comes for treatment: drug misusers at three London agencies. Br J Addict 1988, 82:311-320.
8. Ghodse AH, Tregenza GT: Effect of fear of AIDS on sharing of injection equipment among drug abusers. Br Med J 1987, 295:698.
9. Stimson GV, Alldritt L, Dolan K, Donoghoe M: Syringe exchange schemes for drug users in England and Scotland. Br Med J 1988, 296:1717.
10. Stimson GV, Dolan K, Donoghoe M, Alldritt L: Syringe Exchange 1. Druglink 1988 Vol 3, No 3:10-11.
11. Stimson GV, Donoghoe M, Alldritt L, Dolan K: Syringe exchange 2: The Clients. Druglink 1988 Vol 3, No 4:8-9.
12. Stimson GV, Alldritt L, Dolan K, Donoghoe M: HIV risk behaviour of clients attending syringe exchange schemes in England and Scotland. Br J Addict 1988, 83:12, 1449.
13. Advisory Council on the Misuse of Drugs: AIDS and Drug Misuse. London, Department of Health and Social Security 1988.
14. Cheingsong-Popov R, Weiss RA, Dalgleish A, et al.: Prevalence of antibody to Human T-Lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet 1984, 2:478.
15. Mortimer PP, Jesson WJ, Vandervelde EM, Perelra MS: Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84. Br Med J 1985, 290:1176.
16. Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE: HTLV-II antibody in Edinburgh drug addicts. Lancet 1985, 1:1129.
17. Stimson GV, Alldritt L, Dolan K, Donoghoe M, Lart RA: Injecting Equipment Exchange Schemes: Final Report. London: Goldsmiths' College, 1988.
18. Robertson R, Skidmore C, Roberts JJK: HIV infection in intravenous drug users: a follow-up study indicating changes In risk taking behaviour. Br J Addict 1988, 83:387-391.
19. Scottish Home and Health Department: HIV infection in Scotland. Report of the Scottish Committee on HIV infection and intravenous drug misuse, 1986.
20. Follett EAC, Mclntyre A, O'Donnell B, Clements GB, Desselberger U: HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet 1986, 1:446-447.
21. Donoghoe MC, Stimson GV, Dolan K: Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care 1989, vol 1, No 1.